Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Francesca Chamian"'
Autor:
Yulia Vugmeyster, Francesca Chamian, Edmund Lee, Toyoko Kikuchi, Wolfgang Dummer, Kathy Howell, Michelle A. Lowes, Emma Guttman-Yassky, James G. Krueger, Sarah C. Bodary, Brisdell Hunte, Patricia Gilleaudeau, Mark Kagen
Publikováno v:
Journal of Investigative Dermatology. 128(5):1182-1191
Efalizumab (anti-CD11a) interferes with LFA-1/ICAM-1 binding and inhibits several key steps in psoriasis pathogenesis. This study characterizes the effects of efalizumab on T-cell activation responses and expression of surface markers on human circul
Autor:
Asifa Haider, Irma Cardinale, Kamruz Darabi, Raj Bandaru, Michelle A. Lowes, James G. Krueger, Inna Novitskaya, Francesca Chamian, Humphrey Gardner, Patricia Gilleaudeau, Mary S. Whalen, Toyoko Kikuchi
Publikováno v:
The Journal of Immunology. 178:7442-7449
Alefacept is an LFA3-Ig fusion protein that binds to CD2 and is thought to inhibit T cell activation by antagonism of CD2 signaling or by lysis of CD2+ cells. Alefacept is potential future therapeutic for organ transplant recipients or graft-vs-host
Autor:
Edmund Lee, Michelle A. Lowes, Judilyn Fuentes-Duculan, Frank Wang, Irma Cardinale, Asifa Haider, Francesca Chamian, James G. Krueger, Maria Veronica Abello
Publikováno v:
Journal of Investigative Dermatology. 126(7):1590-1599
We assessed expression of IL-20 and its receptors in psoriasis, given the recent implication of IL-20 in epidermal hyperplasia. Psoriatic lesional (LS) skin consistently expressed more IL-20 mRNA than nonlesional (NL) skin. Immunoreactivity to IL-20
Autor:
Sarah C. Bodary, James G. Krueger, Patricia Gilleaudeau, Yulia Vugmeyster, Michelle A. Lowes, Francesca Chamian, Edmund Lee, Kathy Howell, Toyoko Kikuchi, Wolfgang Dummer, Mark Kagen
Publikováno v:
Clinical Immunology. 113:38-46
Therapeutic administration of efalizumab, a humanized antibody to CD11a, induces a marked but reversible increase of peripheral lymphocytes in psoriasis patients. In this study, 13 patients were treated with 12 weekly subcutaneous doses (2 mg/kg/week
Autor:
Francesca Chamian, James G. Krueger, Madhav V. Dhodapkar, Frank Wang, Judith L. Oestreicher, William L. Trepicchio, Edmund Lee, Debra D. Pittman
Publikováno v:
The Journal of Experimental Medicine
Psoriasis is a type I–deviated disease characterized by the presence of interferon (IFN)-γ and multiple IFN-related inflammatory genes in lesions. Because interleukin (IL)-23 is now recognized to play a role in the recruitment of inflammatory cell
Autor:
Kim A. Papp, Craig L. Leonardi, Francesca Chamian, James G. Krueger, Wolfgang Dummer, Michelle A. Lowes, Maria Veronica Abello
Publikováno v:
BMC Dermatology, Vol 7, Iss 1, p 2 (2007)
BMC Dermatology
BMC Dermatology
Background Newer biological therapies for moderate-to-severe psoriasis are being used more frequently, but unexpected effects may occur. Case presentations We present a group of 15 patients who developed inflammatory papules while on efalizumab thera
Autor:
Edmund Lee, Michelle A. Lowes, Maria Francesca Chamian, James G. Krueger, Jamie L. Harden, Asifa Haider, Craig L. Leonardi, Leanne M. Johnson-Huang, Tillman Pearce
Publikováno v:
Journal of Allergy and Clinical Immunology. 135:553-556.e3
Autor:
Judilyn Fuentes-Duculan, Francesca Chamian, Mary Sullivan-Whalen, Patricia Gilleaudeau, Inna Novitskaya, Michelle A. Lowes, Toyoko Kikuchi, Rachel Nussbaum, Marvin Garovoy, Wolfgang Dummer, Maria Veronica Abello, Shao Lee Lin, Henrietta Carbonaro, Irma Cardinale, Ralph M. Steinman, James G. Krueger, Knut M. Wittkowski, Kim A. Papp
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 102(52)
We find that CD11c + cells with many markers of dendritic cells (DCs) are a major cell type in the skin lesions of psoriasis. These CD11c + cells, which are evident in both epidermis and dermis, are the sites for the expression of two mediators of in
Autor:
Melissa Magliocco, Francesca Chamian, James G. Krueger, Alice B. Gottlieb, Maria Veronica Abello, Irma Cardinale, Michelle A. Lowes, Fei Chen, Salman Masud
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 175(4)
The mechanisms of action of marketed TNF-blocking drugs in lesional tissues are still incompletely understood. Because psoriasis plaques are accessible to repeat biopsy, the effect of TNF/lymphotoxin blockade with etanercept (soluble TNFR) was studie
Autor:
James G. Krueger, Patricia Gilleaudeau, Irma Cardinale, Artemis Khatcherian, Toyoko Kikuchi, Inna Novitskaya, Edmund Lee, Michelle A. Lowes, Knut M. Wittkowski, Francesca Chamian, Shao-Lee Lin, Mary Sullivan-Whalen
Psoriasis vulgaris, a skin disease that is considered to be the result of a type 1 autoimmune response, provides an opportunity for studying the changes that occur in a target-diseased tissue during innovative immunotherapies. To gain a more comprehe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d974f14b6c49328dbd88c531e75e827
https://europepmc.org/articles/PMC545584/
https://europepmc.org/articles/PMC545584/